United Therapeutics (UTHR) Short-term Investments (2009 - 2026)
United Therapeutics' Short-term Investments was $859.1 million in Q2 2026, down 41.0% from $1.46 billion a year earlier and down 1.7% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Short-term Investments (2009 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at United Therapeutics came in at $1.36 billion, down 13.2% from FY2024.
- Short-term Investments has now declined for three consecutive years, though with a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $1.57 billion in FY2024 (-12.1%), $1.79 billion in FY2023 (-4.9%), $1.88 billion in FY2022 (+81.2%) and $1.04 billion in FY2021 (-5.5%).
- The Q2 2026 figure marks the lowest quarterly Short-term Investments since Q1 2020.
- Compared with a year earlier, Short-term Investments has declined for seven straight quarters, with an average decline of 17.0% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q4 2022 (growth of 81.2%); the worst was Q2 2026 (a decline of 41.0%).
- Per Business Quant data, UTHR's Short-term Investments in the three quarters before Q2 2026 was $874 million (Q1 2026), $1.36 billion (Q4 2025) and $1.43 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | United Therapeutics | 23.12 Bn | 12.61 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 859.10 Mn |
| Mar 31, 2026 | 874.00 Mn |
| Dec 31, 2025 | 1.36 Bn |
| Sep 30, 2025 | 1.43 Bn |
| Jun 30, 2025 | 1.46 Bn |
| Mar 31, 2025 | 1.42 Bn |
| Dec 31, 2024 | 1.57 Bn |
| Sep 30, 2024 | 1.77 Bn |
| Jun 30, 2024 | 1.62 Bn |
| Mar 31, 2024 | 1.46 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 1.77 Bn |
| Jun 30, 2023 | 1.61 Bn |
| Mar 31, 2023 | 1.70 Bn |
| Dec 31, 2022 | 1.88 Bn |
| Sep 30, 2022 | 1.65 Bn |
| Jun 30, 2022 | 1.46 Bn |
| Mar 31, 2022 | 1.45 Bn |
| Dec 31, 2021 | 1.04 Bn |
| Sep 30, 2021 | 1.09 Bn |
API Access
United Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();